Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS

[Image: see text] Aberrant changes in site-specific core fucosylation (CF) of serum proteins contribute to cancer development and progression, which enables them as potential diagnostic markers of tumors. An optimized data-dependent acquisition (DDA) workflow involving isobaric tags for relative and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yifei, Zhu, Jianhui, Gutierrez Reyes, Cristian D., Lin, Yu, Tan, Zhijing, Wu, Zuowei, Zhang, Jie, Cano, Alva, Verschleisser, Sara, Mechref, Yehia, Singal, Amit G., Parikh, Neehar D., Lubman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077536/
https://www.ncbi.nlm.nih.gov/pubmed/37033807
http://dx.doi.org/10.1021/acsomega.3c00519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077536/
https://www.ncbi.nlm.nih.gov/pubmed/37033807
http://dx.doi.org/10.1021/acsomega.3c00519

Ejemplares similares